Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzagolix in Endometriosis-Associated Pain
NCT03992846Phase 3Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Jun 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Jun 2019; status: completed.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03992846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03992846.